Concepedia

Publication | Open Access

Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status

44

Citations

26

References

2011

Year

Abstract

Our data suggest that chemotherapy of MHC class I-deficient tumours with 5AC combined with immunotherapy is an attractive setting in the treatment of MHC class I-deficient tumours.

References

YearCitations

Page 1